---
aliases:
- (Elhammady et al., 2017)
author: Elhammady, Mohamed Samy and Heros, Roberto C.
citekey: elhammady2017EditorialARUBAStudy
date_added: '2025-03-23'
doi: 10.3171/2015.7.JNS151408
journal: Journal of Neurosurgery
title: 'Editorial: The ARUBA Study: Where Do We Go from Here?'
year: '2017'

---
# Editorial: The ARUBA Study: Where Do We Go from Here?
- [PDF Link](zotero://open-pdf/library/items/R3MN969S)

Citation: [@elhammady2017EditorialARUBAStudy]
***
# TL;DR (Summary)
- ARUBA trial was prematurely interrupted after 6 years due to excessive morbidity in the intervention group (30.7%) compared to the medical group (10.1%).
- The trial enrolled 223 patients with a mean follow-up of 33.3 months.
- Proposed a new framework for future clinical trials to address ARUBA's shortcomings.
- Introduced the concept of 'care trials' to integrate clinical research with medical care.
- Authors argue that the ARUBA trial's hypothesis was illogical, as intervention should be the experimental arm tested against conservative management.
- Suggest that future trials should test interventions individually and include long-term follow-up (5-10 years).
- Propose assembling a panel of experts to review existing data and classify AVMs into three groups for treatment guidance.
- Highlight the ethical issue of clinical equipoise in randomizing patients to conservative management or intervention.
- Emphasize the need for evidence-based medicine and the burden of proof on proving the effectiveness of interventions.

# 中文摘要 (TL;DR)
- ARUBA試驗在6年後因干預組的過高發病率（30.7%）與醫療組（10.1%）相比而提前中斷。
- 試驗共招募了223名患者，平均隨訪時間為33.3個月。
- 提出了一個新的框架來解決ARUBA試驗的缺陷以設計未來的臨床試驗。
- 引入了“護理試驗”的概念，以將臨床研究與醫療護理整合。
- 作者認為ARUBA試驗的假設是不合邏輯的，因為干預應該是與保守管理對比的實驗組。
- 建議未來試驗應個別測試干預，並包括長期隨訪（5-10年）。
- 提議組建專家小組來審查現有數據，並將AVM分類為三組以指導治療。
- 強調在隨機分配患者至保守管理或干預時的臨床平衡問題。
- 強調需要基於證據的醫學，並強調證明干預有效性的責任。